X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE   ACTAVIS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
ACTAVIS
Dec-14
SUVEN LIFE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs25119,612-   
Low Rs15511,962-   
Sales per share (Unadj.) Rs49.13,531.5-  
Earnings per share (Unadj.) Rs9.7-440.7-  
Cash flow per share (Unadj.) Rs11.4324.0-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs60.37,659.7-  
Shares outstanding (eoy) m127.28265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.5 92.4%   
Avg P/E ratio x20.9-35.8 -58.3%  
P/CF ratio (eoy) x17.848.7 36.6%  
Price / Book Value ratio x3.42.1 163.3%  
Dividend payout %15.40-   
Avg Mkt Cap Rs m25,8254,197,775 0.6%   
No. of employees `0001.121.6 5.0%   
Total wages/salary Rs m6130-   
Avg. sales/employee Rs Th5,832.643,473.5 13.4%   
Avg. wages/employee Rs Th571.50-   
Avg. net profit/employee Rs Th1,153.8-5,425.0 -21.3%   
INCOME DATA
Net Sales Rs m6,253939,027 0.7%  
Other income Rs m233-2,344 -9.9%   
Total revenues Rs m6,485936,684 0.7%   
Gross profit Rs m1,982120,631 1.6%  
Depreciation Rs m213203,334 0.1%   
Interest Rs m4629,619 0.2%   
Profit before tax Rs m1,955-114,665 -1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-8,411 0.0%   
Tax Rs m718-5,895 -12.2%   
Profit after tax Rs m1,237-117,181 -1.1%  
Gross profit margin %31.712.8 246.7%  
Effective tax rate %36.75.1 714.6%   
Net profit margin %19.8-12.5 -158.5%  
BALANCE SHEET DATA
Current assets Rs m5,622494,747 1.1%   
Current liabilities Rs m1,168360,816 0.3%   
Net working cap to sales %71.214.3 499.5%  
Current ratio x4.81.4 351.2%  
Inventory Days Days8158 140.3%  
Debtors Days Days3666 54.2%  
Net fixed assets Rs m3,325114,665 2.9%   
Share capital Rs m1270-   
"Free" reserves Rs m7,5470-   
Net worth Rs m7,6742,036,716 0.4%   
Long term debt Rs m141,067,279 0.0%   
Total assets Rs m9,1353,732,629 0.2%  
Interest coverage x43.2-2.9 -1,505.4%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.70.3 272.1%   
Return on assets %14.0-2.3 -598.8%  
Return on equity %16.1-5.8 -280.1%  
Return on capital %26.0-3.0 -864.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,0650-   
CASH FLOW
From Operations Rs m699161,249 0.4%  
From Investments Rs m-6-386,092 0.0%  
From Financial Activity Rs m-577216,928 -0.3%  
Net Cashflow Rs m116-7,915 -1.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare SUVEN LIFE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NATCO PHARMA  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views On News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Nov 16, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS